the dose-response and the doses required to prevent bradycardia in 50 % ( ed50 ) and 95 % ( ed95 ) of patients were determined for atropine after antagonism of pancuronium-induced neuromuscular blockade in 72 patients with edrophonium-atropine mixtures .
C0004259
atropine
C0717455
edrophonium-atropine